Post-stroke movement disorders: an analysis of 24 cases
Objective: To define prevalence of post-stroke movement disorders and correlate their clinical presentation with infarct localisation. Background: Stroke related movement disorders are rare, they can…Use of syringe driver in End of Life Care in Parkinson’s Disease (PD)
Objective: To evaluate our current practice in the use of syringe drivers in End of Life Care in Parkinson’s Disease. Background: Palliative care in advanced…Factors Influencing Decision-Making About End of Life Care in Patients With Parkinson’s Disease and Their Family Members
Objective: The aim of the research was to determine factors influencing decision-making about end of life care in patients with Parkinson´s disease (PD) and their…The effect of levodopa on speech in advanced Parkinson’s Disease: acoustic analysis and correlation with motor features and dyskinesia
Objective: Analyse the effects of levodopa on speech and its possible relationship with motor features and dyskinesias in a group of advanced Parkinson’s disease (PD)…Movement disorders associated with autoimmune encephalitis
Objective: We aim to highlight the spectrum of movement disorders in patients of autoimmune encephalitis (AE) diagnosed at our tertiary care center and describe their…Movement Disorders in Post Stroke Patients: A Retrospective Analysis
Objective: To review the prevalence of various movement disorders in post stroke patients at a tertiary, academic center and to characterize the therapeutic response to…Rhythmic disorders in idiopathic RBD: a potential new marker for future PD?
Objective: The aim of our study is to compare rhythmic skills in patients with idiopathic REM sleep behaviour disorder (IRBD), healthy controls, and patients with…Movement disorders as a clinical feature of Subacute Sclerosing Pan Encephalitis: Expansion of phenotypic spectrum
Objective: To study the frequency of movement Disorders(MD) in patients with Subacute Sclerosing Pan Encephalitis (SSPE). To describe the various type of MD in patients with…Investigation into the causes of reduced caffeine levels in Parkinson’s disease
Objective: To find out whether PD patients show decreased salivary caffeine levels; to investigate CYP1A2-phenotype and caffeine absorption as possible causes of decreased caffeine levels…High Content Screening of synucleinopathy in primary cortical neurons : dissecting out the interplay between the basic synuclein pools
Objective: To set up a robust (see ref 1 for definition) 96-well High Content Screening assay of synucleinopathy in primary cultures of cortical neurons. Background:…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.